Compare Ramayana Lestari Sentosa Tbk. (RALS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ramayana Lestari Sentosa Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Ramayana Lestari Sentosa Tbk. trades at Rp380 (market cap 2.7T), while Tempo Scan Pacific Tbk. trades at Rp2,790 (market cap 12.58T). The key difference: Tempo Scan Pacific Tbk. is far larger — about 4.7× Ramayana Lestari Sentosa Tbk.'s market cap. Which is the better fit depends on your goals.
| RALS | TSPC | |
|---|---|---|
Market Cap | 2.7T | 12.58T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ramayana Lestari Sentosa Tbk.
PT Ramayana Lestari Sentosa (the Company) was established on December 14, 1983. The Company’s Articles of Association has been amended several times, the latest amended concerning changes in the Company’s authorized capital stock.As december 31, 1999, the Company operates a total of 57 department stores known as Ramayana, Robinson, Bazaaria and 7 department stores known as Cahaya and Jayasera, located in Jakarta, Tangerang, Bekasi, Bogor, Depok, Sukabumi, Bandung, Cimahi, Cirebon, Cilegon, Semarang, Yogyakarta, Surabaya, Gresik, Sidoarjo, Malang, Bali, Lampung and Batam. As September 2001, The Company operates a total of 77 department stores and until the end of 2001 the company plans to open 5 department stores more.The Company started its commercials operations in 1983.
Read more on RALS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
